FDA Third Class Thoughts Expected In Months; Agency Wants Industry Input

FDA will include industry in the process of developing distribution channels between traditional Rx and OTC spaces, agency representatives told attendees of Consumer Healthcare Products Association's Regulatory and Scientific Conference

More from Archive

More from Pink Sheet